Investigation of the safety and effectiveness of fractional CO2 laser in combination with topical minoxidil 15% in the treatment of patients with androgenetic hair loss.

Evaluating the safety and efficacy of fractional CO2 laser in combination with topical minoxidil 15% compared to topical minoxidil 15% alone in the treatment of patients with androgenetic hair loss: a single-blind clinical trial study

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N50

Enrollment

Registered

2024-07-17

Start date

2024-07-20

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia. Androgenic alopecia, unspecified

Interventions

Intervention 1: Intervention group: The head area of ??the patients will be treated with CO2 laser three times with a one month interval, and minoxidil 15% will be used topically twice a day for three

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Not using topical or oral medication for the treatment of alopecia during the last six months AGA type 2-4

Exclusion criteria

Exclusion criteria: Age under18 years pregnancy breastfeeding History of malignant diseases Taking any topical or systemic treatment during the study

Design outcomes

Primary

Measure	Time frame
Hair density. Timepoint: before starting the treatment and one month after the end of the treatment period (end of the fourth month). Method of measurement: Biometric examination will be done and the findings from VISIOFACE and TES-TB (hair loss type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens) It will be recorded for each patient.	—

Measure

Time frame

Hair density. Timepoint: before starting the treatment and one month after the end of the treatment period (end of the fourth month). Method of measurement: Biometric examination will be done and the findings from VISIOFACE and TES-TB (hair loss type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens) It will be recorded for each patient.

—

Secondary

Measure	Time frame
Side effects. Timepoint: At the time of the laser. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: satisfaction. Method of measurement: Satisfaction Questionnaire and visit.;Tolerability. Timepoint: At the time of the laser. Method of measurement: Questionnaire and visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem Cell Research Center, Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026